Research Article Details
| Article ID: | A12862 |
| PMID: | 30250893 |
| Source: | Mol Cell Oncol |
| Title: | Cisd2 haploinsufficiency: A driving force for hepatocellular carcinoma. |
| Abstract: | Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and is the major risk factor leading to hepatocellular carcinoma (HCC). Cisd2 haploinsufficiency in mice causes NAFLD by disrupting Ca2+ homeostasis, indicating that CISD2 is a molecular target for the treatment of NAFLD and the prevention of HCC. |
| DOI: | 10.1080/23723556.2018.1441627 |
| Strategy ID | Therapy Strategy | Synonyms | Therapy Targets | Therapy Drugs |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|